RR
Rajamani Rajeswari Ayyappankavu
About Rajamani Rajeswari Ayyappankavu
Data last updated:
Rajamani Rajeswari Ayyappankavu is an Additional Director at Procule Laboratories Private Limited (since 2023) and Director at Prokare Therapeutics Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Procule Laboratories Private Limited at ₹12.73 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Procule Laboratories Private Limited U24239AP2021PTC118268 | Additional Director | 19 Jul 2023 | 2021 | ₹12.73 Cr (FY 2025) | Active |
| Prokare Therapeutics Private Limited U26600AP2023PTC110933 | Director | 26 Apr 2023 | 2023 | Active |
Board colleagues of Rajamani Rajeswari Ayyappankavu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Paturi Vijaya Lakshmi | 09175406 | Procule Laboratories Private Limited | Director |
| Surendra Kumar Paturi | 09175405 | Procule Laboratories Private Limited | Additional Director |
| Kalaiselvi | 09443523 | Prokare Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajamani Rajeswari Ayyappankavu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajamani Rajeswari Ayyappankavu
Rajamani Rajeswari Ayyappankavu currently holds 2 directorships: Procule Laboratories Private Limited (Additional Director, since 19 Jul 2023, revenue ₹12.73 Cr (FY 2025)); Prokare Therapeutics Private Limited (Director, since 26 Apr 2023).
Rajamani Rajeswari Ayyappankavu was first appointed on 26 Apr 2023 as Director at Prokare Therapeutics Private Limited.
The current boards of Rajamani Rajeswari Ayyappankavu's companies include Paturi Vijaya Lakshmi (Procule Laboratories Private Limited), Surendra Kumar Paturi (Procule Laboratories Private Limited), Kalaiselvi (Prokare Therapeutics Private Limited).